Clancy Mullan, MD

Raised in Raleigh, North Carolina, Clancy attended the University of North Carolina at Chapel Hill for his undergraduate degrees in Chemistry (Biochemistry, Honors and Distinction) and Traditional Mathematics. While there, he worked in the Department of Genetics under Dr. Mark Heise, studying non-coding complementary strand transcription products of alphaviruses and working on validating a methodology of producing sequence independent cDNA libraries from multiple RNA viruses. He then attended the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.  While a student, he studied the role of nicotinic signaling in mitochondrial membrane preservation during ischemic preconditioning with Dr. Kaie Ojamaa.  He was selected for Alpha Omega Alpha and received the 2018 graduation award from the Department of Thoracic and Cardiovascular Surgery.  Since joining the Yale Integrated Thoracic Surgery program, he has produced numerous outcomes research publications using institutional, national, and international databases.  He continues his basic science training during his research hiatus as a graduate student in the Investigative Medicine Program. In the lab of Dr. Jordan Pober, he is studying endothelial alloreactivity, NF-κB regulation of endothelial cytokine expression, and novel nucleotide-based therapeutics during ex vivo organ perfusion to reduce alloreactivity.  He plans to pursue a career in surgical heart failure.